Xencor, Inc.
BISPECIFIC AND MONOSPECIFIC ANTIBODIES USING NOVEL ANTI-PD-1 SEQUENCES
Last updated:
Abstract:
The present invention is directed to bispecific, heterodimeric checkpoint antibodies.
Status:
Application
Type:
Utility
Filling date:
16 Mar 2022
Issue date:
30 Jun 2022